Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial

MLA

Daisuke Kawai, et al. “Vonoprazan versus Lansoprazole in the Treatment of Artificial Gastric Ulcers after Endoscopic Submucossal Dissection: A Randomized, Open-Label Trial.” BMC Gastroenterology, vol. 21, no. 1, May 2021, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s12876-021-01822-5.

APA

Daisuke Kawai, Ryuta Takenaka, Mikako Ishiguro, Shotaro Okanoue, Tatsuhiro Gotoda, Yoshiyasu Kono, Koji Takemoto, Hirofumi Tsugeno, & Shigeatsu Fujiki. (2021). Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial. BMC Gastroenterology, 21(1), 1–6. https://doi.org/10.1186/s12876-021-01822-5

Chicago

Daisuke Kawai, Ryuta Takenaka, Mikako Ishiguro, Shotaro Okanoue, Tatsuhiro Gotoda, Yoshiyasu Kono, Koji Takemoto, Hirofumi Tsugeno, and Shigeatsu Fujiki. 2021. “Vonoprazan versus Lansoprazole in the Treatment of Artificial Gastric Ulcers after Endoscopic Submucossal Dissection: A Randomized, Open-Label Trial.” BMC Gastroenterology 21 (1): 1–6. doi:10.1186/s12876-021-01822-5.